mcr-1 and blaKPC-3 in Escherichia coli Sequence Type 744 after Meropenem and Colistin Therapy, Portugal
Escherichia coli Ec36 was recovered from a patient in Portugal after treatment with meropenem and colistin. Besides an IncF plasmid with Tn1441d-blaKPC-3, already reported in clinical strains in this country, E. coli Ec36 co-harbored an IncX4::mcr-1 gene. Results highlight emerging co-resistance to...
Main Authors: | Marta Tacão, Rafael dos Santos Tavares, Pedro Teixeira, Inês Roxo, Elmano Ramalheira, Sónia Ferreira, Isabel Henriques |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2017-08-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/23/8/17-0162_article |
Similar Items
-
Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
by: Shrief R, et al.
Published: (2022-10-01) -
Adverse Drug Reactions Relevant to Drug Resistance and Ineffectiveness Associated with Meropenem, Linezolid, and Colistin: An Analysis Based on Spontaneous Reports from the European Pharmacovigilance Database
by: Bogdan Ioan Vintila, et al.
Published: (2023-05-01) -
In vitro Synergistic Activity of Ceftazidime-Avibactam in Combination with Aztreonam or Meropenem Against Clinical Enterobacterales Producing blaKPC or blaNDM
by: Kuai J, et al.
Published: (2023-05-01) -
Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021-07-01) -
A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant <i>Acinetobacter baumannii</i> in Critically Ill Patients: A Propensity Score-Matched Analysis
by: Wasan Katip, et al.
Published: (2020-09-01)